Hypersensitivity i ii ch 18 19 l.jpg
This presentation is the property of its rightful owner.
Sponsored Links
1 / 47

Hypersensitivity I & II Ch. 18-19 PowerPoint PPT Presentation


  • 154 Views
  • Uploaded on
  • Presentation posted in: General

Hypersensitivity I & II Ch. 18-19 . March 6th, 2006 Ricky Chang. Objectives. Know the mechanism of Type I hypersensitivity Know the mediators of Type I hypersensitivity Know the diseases associated with Type II hypersensitivity. Hypersensitivity.

Download Presentation

Hypersensitivity I & II Ch. 18-19

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Hypersensitivity i ii ch 18 19 l.jpg

Hypersensitivity I & IICh. 18-19

March 6th, 2006

Ricky Chang


Objectives l.jpg

Objectives

  • Know the mechanism of Type I hypersensitivity

  • Know the mediators of Type I hypersensitivity

  • Know the diseases associated with Type II hypersensitivity


Hypersensitivity l.jpg

Hypersensitivity

  • Adaptive immunity is important against microbial infections, but it is also capable of causing tissue injury and disease (autoimmune diseases)

  • Occurs when immune responses are directed against self-ag and also from uncontrolled or excessive responses to against foreign ag, such as microbes and allergens


Hypersensitivity4 l.jpg

Hypersensitivity

  • Common cause is failure of self-tolerance, which ensures that individuals do not respond to their own antigens

  • Leads to tissue injury that occurs in autoimmune diseases due to the same effector mechanisms used to protect against microbes


Hypersensitivity5 l.jpg

Hypersensitivity

  • Type I: IgE antibodies bind to Fc receptors on mast cells. IgE induces mast cell degranulation and release inflammatory mediators

  • Type II: Ab mediated immune response against self antigen or foreign antigen (ie ag on transfused RBC)

  • Type III: Immune complexes are deposited in tissue

  • Type IV: T-cell mediated response where Ag sensitized T-cells release lymphokines


Hypersensitivity6 l.jpg

Hypersensitivity


Hypersensitivity7 l.jpg

Hypersensitivity


Roles of mast cells l.jpg

Roles of Mast Cells

  • Part of connective tissue (contains granules of histamine and heparin)

  • Allergic diseases (asthma,eczema,itch)

  • Anaphylaxis (systemic shock to allergens such as bee sting,nuts,drugs)

  • Autoimmune disorders/Acute or chronic inflammation (MS, Rheumatoid arthritis)

  • Wound healing

  • Innate response for clearing bacteria and viruses


Slide9 l.jpg

Mast Cell

Basophil


Type i immediate l.jpg

Ag/allergen stimulate CD4+Th2

Th2 releases IL-4, which promote B-cells specific for that Ag to differentiate into IgE producing cells

Circulating IgE binds to Fc receptors on mast cells and basophils

Elicits a transduction event to release mediators stored in granules (Degranulation)

Immediate hypersensitivity response (5-10 minutes)

Type I (Immediate)


Slide11 l.jpg

Mediator Release from Mast Cells


Type i mediators and effects l.jpg

Type I Mediators and Effects

Figure19.3


Type i mediators and effects13 l.jpg

Type I Mediators and Effects


Ige mediated allergic reactions l.jpg

IgE-Mediated Allergic Reactions


Type i mast cells l.jpg

Type I: Mast Cells

  • Type I reaction is dependent upon the specific triggering of IgE-sensitizedmast-cells by allergen (Ag)

  • Ag enter via mucosal surfaces and are taken up by APC

  • Th2 cells release IL-4 to facilitate the B-cell proliferation and differentiation, producing IgE specific for the allergen

  • REMEMBER: THIS IS A TH2 RESPONSE!


Activation of mast cells l.jpg

Activation of Mast Cells

  • IgE from B-cells binds to FcRI on mast-cells

    - is the heavy chain responsible for IgE isotype switching

  • FcRI on mast-cells cross-links with Ag-bounded IgE and induces degranulation of mediators


Slide17 l.jpg

Cross-linking of FcRI to

IgE bounded to Ag

Degranulation of Mediators


Activation of mast cells18 l.jpg

Activation of Mast-cells

Cross-linking


Mast cell mediators l.jpg

Mast-Cell Mediators

  • Inflammatory Mediators released

    -Histamine

    -Proteases (tryptase or chymase), acid hydrolases

    -Proteoglycans (heparin, chondroitin sulfate)


Mast cells lipid mediators l.jpg

Mast Cells: Lipid Mediators

  • Prostaglandins D2

  • Leukotrienes C4, D4, E4

  • Platelet-activating factor


Mast cells cytokines l.jpg

Mast-Cells: Cytokines

  • IL-3: Promote mast cell proliferation

  • IL-4, IL-5: Promote Th2 differentiation and IgE AB production

  • TNF-, MIP-1 : Enhance inflammatory reaction


Allergen induced hypersensitivity l.jpg

Allergen Induced Hypersensitivity

  • Allergen: are antigens that induce production of specific IgE AB

  • Examples: plant pollens, dust, animal hair, animal anti-serum, insect venom, chemicals, and foods

  • Once the allergen reaches the sensitized mast cells, the allergen crosslinks the surface-bound IgE intracelluar Ca+2 and triggers degranulation of mediators


Atopy l.jpg

Atopy

  • Atopy: Describes individuals that produce IgE AB in response to various environmental Ag and develop immediate hypersensitivity (Type I) responses.(Asthma, eczema, hay fever, and urticaria)

  • These individuals normally have a strong family history (autosomal transmission of atopy)


Atopy25 l.jpg

Atopy

  • HLA vs. Allergen Responsiveness

    -Some allergens response have a relationship to HLA

    -HLA-DR2 and HLA-A2: high responder to low dos of ragweed

    -HLA-B8: high responder to ragweed and also associated to other forms of hyperimmunity (autoimmunity)


Slide26 l.jpg

IgE

  • IgE blood concentrations are often increased in allergic disease and are grossly elevated in parasitic infections

  • IL-4: promote B-cells to differentiate into IgE-producing specific cells


Eosinophil l.jpg

Eosinophil

  • Th2 produce IL-5: Promotes the synthesis and secretion of IgA from B-cells and also important in stimulating eosinophil development and activation

  • IL-4 and IL-5 production by Th2 cells may account for the eosinophilia seen in type I hypersensitivity and parasitemia


Two types of mast cells l.jpg

Two Types of Mast Cells

  • Connective tissue mast cells (CTMCs)

  • Mucosal mast cells (MMC)


Connective tissue mass cells l.jpg

Connective Tissue Mass Cells

  • CTMCs are found most in blood vessels but vary in size and number of granules at different regions of the body

  • Diseases such as Crohn’s disease, ulcerative colitis, and RA all present with increase in CTMCs


Types of fc receptors for ige l.jpg

Types of Fc Receptors for IgE

  • There are two types of receptors for IgE

    1) FcRI (high affinity): Expressed on mast cells and basophils

    2) FcRII (low affinity): Expressed by lymphocytes


Mast cells activation l.jpg

Mast Cells Activation

  • Cross-linking can be artificially induced with lectins such as PHA (Polyhydroxyaldehyde) and ConA

  • These carbohydrates cross-link with IgE and cause degranulation

  • This explains urticaria in individuals allergic to fruits (ie strawberries-contain large amt of lectin


Degranulation l.jpg

Degranulation

  • C’ products of C3a and C5a are very active in degranulating mast cells

  • Compounds that affect Ca+2 influx into mast cells can induce degranulation

  • Drugs such as morphine, codeine, synthetic ACTH can create clinical manifestations related to mast cells


Modulation of mast cells l.jpg

Modulation of Mast Cells


Therapy for allergy l.jpg

Therapy for Allergy

1) Agents that increase intracellular cAMP (-agonist)-inhibits contraction

-Theophyllines: Prevents cAMP degradation

2) Blocking mediator release, such as sodium cromolyn: mechanism not clear, but seem to antagonize IgE-induced mediator release.


Therapeutics l.jpg

Therapeutics

  • Direct Inhibitors

    -Theophyllines, Xanthines

    -Sodium cromolyn

    -Epinephrine

    -PGE1, PGE2

  • Indirect Inhibitor

    -Glucocorticoids


Histamine receptors l.jpg

H1

Bronchial constriction

Musous secretion

Intestinal smooth muscle contraction

Itching and pain at sensory nerve endings

H1 and H2

Reduces BP

Increase permeability in skin

H2

- Gastric secretion in stomach

Histamine Receptors


Antihistamines l.jpg

Nausea,vertigo,motion sickness

-Cyclizine

-Dimenhydrinate

-Diphenhydramine (Benadryl, Tylenol PM)

-Meclizine

H1 Antagonists

-Promethazine (Phenergan)

-Cetirizine (Zyrtec)

-Desloratadine (Clarinex)

-Fexofenadine (Allegra)

-Loratadine (Claritin)

Antihistamines


Type ii hypersensitivity l.jpg

Type II Hypersensitivity


Type ii l.jpg

Type II

  • Antibodies are directed against ag on particular cells/tissue or extracellular matrix, causing damage (ie RBC transfusion)

  • These cell- or tissue-specific Ab cause diseases

    -Myasthenia Gravis: Ab blocks Ach-binding and cause muscle weakness and paralysis

    -Graves’ Disease: Ab stimulate TSH and casue hyperthyroidism)


Type ii40 l.jpg

Type II


Type ii41 l.jpg

Type II

  • Type II causes disease by 3 mechanism

    1) Opsonization and phagocytosis of cells

    2) Complement and Fc receptor-mediated inflammation and tissue injury

    3) Interference of normal cellular function by binding to important molecules or receptors


Reaction against rbcs and platelets l.jpg

Reaction Against RBCs and Platelets

  • Transfusion Reactions: There are 200 genetic variant of the RBC, but the ABO is the main designation

  • The Rh system is also important because its cause of hemolytic disease in the newborn


Reaction against rbcs and platelets43 l.jpg

Reaction Against RBCs and Platelets


Reaction against rbcs and platelets44 l.jpg

Reaction Against RBCs and Platelets

  • Hemolytic disease of the newborn (2nd born)

    -RhoGam: It’s an Anti-Rh+ Antibody given to mother after the first born to prevent future complications in later newborns

  • Autoimmune Hemolytic Anemia

    -When provoked by allergic reactions to certain drugs, including Penicillin, quinine, and sulphonamides


Idiopathic thrombocytpenic purpura itp l.jpg

Idiopathic Thrombocytpenic Purpura (ITP)

  • Autoantibody to platelets from the rapid removal of platelets from circulation

  • Most often develop in women after bacterial or viral infections

  • Associated with autoimmune disease Systemic Lupus Erythematosus (SLE)


Type ii mediated autoimmune diseases l.jpg

Type II Mediated Autoimmune Diseases

  • Myasthenia Gravis

  • Graves’ Disease

  • Insulin-resistance Diabetes

  • Hemolytic Anemia

  • Rheumatoid Arthritis


Slide47 l.jpg

Advise of the Day

TYPE III & Type IV..To Be Continued…


  • Login